Full approval of Vitrakvi was based on results from three clinical trials in patients with unresectable or metastatic NTRK ...

In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra ...

Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.

Financing of Merida Biosciences was backed by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, with ...

Davidi Vortman, CEO, UltraSight, discusses how AI-powered heart scan technology can help high-risk cardiovascular disease ...

PharmaLogic states that the acquisition of Agilera Pharma AS will place the company in a unique global role in ...

CVS Health announced that Brian Newman will serve as executive vice president and chief financial officer (CFO) starting on ...

As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not ...

Rahman discusses Google Gemini and what it could mean to the future of pharma commercialization and content development.

The survey also suggests that Medicaid is broadly popular amongst all Americans, regardless of political affiliation.

Approval of the Opdivo plus Yervoy combination regimen was based on results from the Phase III CheckMate-8HW trial, which was ...